[96a5a0]: / output / allTrials / identified / NCT04640480_identified.json

Download this file

466 lines (466 with data), 20.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
{
"info": {
"nct_id": "NCT04640480",
"official_title": "A Phase I, Open-Label, Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Infused SNB-101(as SN-38) in Patients With Advanced Solid Tumors",
"inclusion_criteria": "* Patients with a histologically or cytologically confirmed, locally advanced or metastatic disease, has progressed after systemic standard of care treatment for advanced disease and is not suitable for complete surgical resection.\n* Patients with measurable or evaluable disease consistent with Response Evaluation Criteria in Solid Tumors version 1.1.\n* Patients ambulatory with an Eastern Cooperative Oncology Group performance score of 0 or 1.\n* Patients with adequate hematological, renal, and liver function(CTCAE V5.0 grade 1 or lower).\n* Patients with the life expectancy of 3 months or longer.\nHealthy volunteers allowed\nMust have minimum age of 19 Years",
"exclusion_criteria": "* Patients homozygous for UGT1A1*28 or UGT1A1*6 alleles.\n* Patients known or suspected intolerance or hypersensitivity to main ingredient or any of the excipients of SNB-101.\n* Patients with unintentional weight loss >10% within 3 months prior to screening.\n* Patients who are on dialysis.\n* Patients who are positive for HIVs.\n* Patients with a QT interval with Fridericia's correction outside of normal.\n* Patients with intestinal palsy or bowel obstruction.\n* Patients with chronic inflammatory bowel disease.\n* Patients who may require administration of neuromuscular blockers, peripheral muscle relaxants, etc. during the study.\n* Patients who may require lapatinib during the study.\n* Patients who may require attenuated vaccine during the study.\n* Patients who are taking any medication that in the judgement of the investigator could have an effect on the action of SNB-101.\n* Patients unable to participate in the study as judged by the investigator.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with a histologically or cytologically confirmed, locally advanced or metastatic disease, has progressed after systemic standard of care treatment for advanced disease and is not suitable for complete surgical resection.",
"criterions": [
{
"exact_snippets": "histologically or cytologically confirmed",
"criterion": "disease confirmation",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "locally advanced or metastatic disease",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "has progressed after systemic standard of care treatment for advanced disease",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "progression",
"expected_value": true
}
]
},
{
"exact_snippets": "is not suitable for complete surgical resection",
"criterion": "surgical resection suitability",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with measurable or evaluable disease consistent with Response Evaluation Criteria in Solid Tumors version 1.1.",
"criterions": [
{
"exact_snippets": "measurable or evaluable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"measurable",
"evaluable"
]
}
]
},
{
"exact_snippets": "consistent with Response Evaluation Criteria in Solid Tumors version 1.1",
"criterion": "consistency with RECIST 1.1",
"requirements": [
{
"requirement_type": "consistency",
"expected_value": "RECIST 1.1"
}
]
}
]
},
{
"line": "* Patients ambulatory with an Eastern Cooperative Oncology Group performance score of 0 or 1.",
"criterions": [
{
"exact_snippets": "ambulatory",
"criterion": "ambulatory status",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
},
{
"exact_snippets": "Eastern Cooperative Oncology Group performance score of 0 or 1",
"criterion": "ECOG performance score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"comparisons": [
{
"operator": "=",
"value": 0,
"unit": "N/A"
},
{
"operator": "=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Patients with the life expectancy of 3 months or longer.",
"criterions": [
{
"exact_snippets": "life expectancy of 3 months or longer",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": "minimum age of 19 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients homozygous for UGT1A1*28 or UGT1A1*6 alleles.",
"criterions": [
{
"exact_snippets": "Patients homozygous for UGT1A1*28",
"criterion": "UGT1A1*28 allele",
"requirements": [
{
"requirement_type": "homozygosity",
"expected_value": true
}
]
},
{
"exact_snippets": "Patients homozygous for ... UGT1A1*6 alleles",
"criterion": "UGT1A1*6 allele",
"requirements": [
{
"requirement_type": "homozygosity",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients known or suspected intolerance or hypersensitivity to main ingredient or any of the excipients of SNB-101.",
"criterions": [
{
"exact_snippets": "intolerance or hypersensitivity to main ingredient",
"criterion": "intolerance or hypersensitivity to main ingredient",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "intolerance or hypersensitivity to ... any of the excipients of SNB-101",
"criterion": "intolerance or hypersensitivity to excipients of SNB-101",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with unintentional weight loss >10% within 3 months prior to screening.",
"criterions": [
{
"exact_snippets": "unintentional weight loss >10% within 3 months prior to screening",
"criterion": "unintentional weight loss",
"requirements": [
{
"requirement_type": "percentage",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "%"
}
},
{
"requirement_type": "time frame",
"expected_value": "within 3 months prior to screening"
}
]
}
]
},
{
"line": "* Patients who are on dialysis.",
"criterions": [
{
"exact_snippets": "Patients who are on dialysis.",
"criterion": "dialysis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who are positive for HIVs.",
"criterions": [
{
"exact_snippets": "positive for HIVs",
"criterion": "HIV status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with a QT interval with Fridericia's correction outside of normal.",
"criterions": [
{
"exact_snippets": "QT interval with Fridericia's correction outside of normal",
"criterion": "QT interval with Fridericia's correction",
"requirements": [
{
"requirement_type": "range",
"expected_value": "outside of normal"
}
]
}
]
},
{
"line": "* Patients with intestinal palsy or bowel obstruction.",
"criterions": [
{
"exact_snippets": "Patients with intestinal palsy",
"criterion": "intestinal palsy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "bowel obstruction",
"criterion": "bowel obstruction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with chronic inflammatory bowel disease.",
"criterions": [
{
"exact_snippets": "chronic inflammatory bowel disease",
"criterion": "chronic inflammatory bowel disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who may require administration of neuromuscular blockers, peripheral muscle relaxants, etc. during the study.",
"criterions": [
{
"exact_snippets": "Patients who may require administration of neuromuscular blockers",
"criterion": "requirement for neuromuscular blockers",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
},
{
"exact_snippets": "Patients who may require administration of ... peripheral muscle relaxants",
"criterion": "requirement for peripheral muscle relaxants",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who may require lapatinib during the study.",
"criterions": [
{
"exact_snippets": "Patients who may require lapatinib during the study.",
"criterion": "lapatinib requirement",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who may require attenuated vaccine during the study.",
"criterions": [
{
"exact_snippets": "Patients who may require attenuated vaccine during the study.",
"criterion": "attenuated vaccine requirement",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who are taking any medication that in the judgement of the investigator could have an effect on the action of SNB-101.",
"criterions": [
{
"exact_snippets": "Patients who are taking any medication",
"criterion": "medication use",
"requirements": [
{
"requirement_type": "effect on SNB-101",
"expected_value": "could have an effect"
}
]
}
]
},
{
"line": "* Patients unable to participate in the study as judged by the investigator.",
"criterions": [
{
"exact_snippets": "Patients unable to participate in the study as judged by the investigator.",
"criterion": "ability to participate",
"requirements": [
{
"requirement_type": "judgment",
"expected_value": "investigator's discretion"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Patients with adequate hematological, renal, and liver function(CTCAE V5.0 grade 1 or lower).",
"criterions": [
{
"exact_snippets": "adequate hematological ... (CTCAE V5.0 grade 1 or lower)",
"criterion": "hematological function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "CTCAE V5.0 grade 1 or lower"
}
]
},
{
"exact_snippets": "adequate ... renal function(CTCAE V5.0 grade 1 or lower)",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "CTCAE V5.0 grade 1 or lower"
}
]
},
{
"exact_snippets": "adequate ... liver function(CTCAE V5.0 grade 1 or lower)",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "CTCAE V5.0 grade 1 or lower"
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}